跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 51,750 条关于
“Thryv Therapeutics Inc.”
全部
51,750
临床试验
14,622
药物
4,503
机构
6,558
资讯
26,067
去年
Thryv Therapeutics Unveils Breakthrough SGK1 Inhibitor Data for Heart Failure and Long QT Syndrome at ESC Congress 2025
去年
Atrial Fibrillation Pipeline Shows Robust Development with 15+ Novel Therapies from Leading Pharmaceutical Companies
去年
LQT-1213 Receives FDA Orphan Drug Designation for Long QT Syndrome Treatment
14天前
Thryv Therapeutics licenses structurally distinct SGK1 inhibitors to expand into Parkinson's and Alzheimer's disease
4个月前
Thryv Therapeutics Initiates Phase 2/3 Trial for Long QT Syndrome Treatment, Receives FDA Fast Track Designation
去年
Virios Therapeutics and Wex Pharmaceuticals Merge to Form Dogwood Therapeutics, Advancing Novel Pain and Viral Therapies
2年前
Axsome Therapeutics Reports Strong Q1 2024 Financial Results and Pipeline Advancements
去年
Error parsing response
去年
Stoke Therapeutics Advances Dravet Syndrome Treatment with Zorevunersen
去年
Soleno Therapeutics Faces Losses Despite DCCR Progress for Prader-Willi Syndrome
第 1 页,共 2607 页
上一页
下一页